New daily pill aims to ease diabetic eye swelling
Disease control
Not yet recruiting
This study tests an oral medication, CU06-1004, taken once daily for 24 weeks in about 156 people with diabetic macular edema (DME), a condition that causes vision loss due to swelling in the center of the retina. Participants are randomly assigned to receive a low dose, a high d…
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC